Epigenomics Biodesix, Sera Prognostics, Aspira, Epigenomics Post Q1 Financial Results All four companies posted net losses for the quarter, while Biodesix's results were hit by a sharp decline in COVID-19 testing revenue. Epigenomics Posts Strong Revenue Gains in 2021 on Blood Biobank Sale Sales of the company's Epi proColon blood-based colorectal cancer test dropped 33 percent, in part due to reimbursement troubles in the US. People in the News: New Appointments at Myriad Genetics, NeoGenomics, Epigenomics, More People in the News: New Appointments at Rebus Biosystems, Jumpcode Genomics, Epigenomics, More In Brief This Week: Caris Life Sciences, Psomagen, Tempus, CareDx, HTG Molecular, Epigenomics, More News items for the week of Nov 8, 2021. Aug 11, 2021 Epigenomics H1 Revenues Down 31 Percent Mar 25, 2021 Epigenomics Reports 24 Percent Drop in 2020 Revenues, Seeks Sale After Negative Coverage Decision Jan 20, 2021 CMS Finalizes Blood-Based Colon Cancer Screening NCD with Non-Coverage for Epi ProColon Jan 7, 2021 Epigenomics Issues €5.5M Convertible Bond Nov 12, 2020 Epigenomics Posts 30 Percent Rise in Q3 Revenues Aug 13, 2020 Epigenomics Q2 Revenues Slide 76 Percent on Coronavirus Challenges May 7, 2020 Epigenomics Q1 Revenues Down 28 Percent Apr 29, 2020 Epigenomics Preliminary Q1 Revenues Drop 33 Percent Feb 29, 2020 CMS Seeks Public Input on Epigenomics' National Coverage Request for Colon Cancer Screening Test Nov 19, 2019 Epigenomics Posts 69 Percent Drop in Q3 Revenues Aug 7, 2019 Epigenomics Q2 Revenues Slide 25 Percent May 10, 2019 Guardant Health Announces Plans for Prospective Colorectal Cancer Screening Study Premium May 8, 2019 Epigenomics Q1 Revenues Rise 7 Percent Mar 27, 2019 Epigenomics 2018 Revenues Down 21 Percent Mar 13, 2019 BioChain Threatens Legal Action Against Epigenomics for Contract Termination Mar 6, 2019 Epigenomics Terminates BioChain Licensing Deal; Provides 2019 Revenue Outlook Dec 27, 2018 Epigenomics Pushes New Promotion Efforts for ProColon Test as Other Assays in Pipeline Advance Premium Dec 21, 2018 In Brief This Week: QuantuMDx, Molbio, Seegene, Qiagen, Epigenomics, More Nov 7, 2018 Epigenomics Posts 57 Percent Rise in Q3 Revenues Aug 8, 2018 Epigenomics Posts 88 Percent Increase in Q2 Revenues Load More Breaking News Mitochondrial Protein Resource Reveals New Disease Players StageZero Life Sciences, DiagnoseAtHome Partner on Multicancer Blood Test OraSure Technologies Selected by HHS to Provide COVID-19 School Testing Hologic Obtains CE Mark for Molecular Epstein-Barr, BK Virus Assays Multiomics Startup Pleno Closes $15M Funding Round SeekIn Gets CE Mark for Cancer Treatment Response Monitoring Kit The Scan UK Moves to Allow Sale of Gene-Edited Food The UK is moving ahead to allow the sale of gene-edited food in England, Scotland, and Wales, according to New Scientist. Questions for the Field Stat News writes that the alleged Buffalo shooter's citation of genetics research raises questions about what the field can do. Cell Studies on Tumor Evolution in Mouse Model of Lung Cancer, Stereo-seq, Bacteriophage Responses In Cell this week: tumor evolution tracked in mouse model of lung cancer, organogenesis mapped using Stereo-seq, and more. Taking Stock of the Stockpile The US and European countries are evaluating their smallpox vaccine stockpiles as the number of monkeypox cases increases, the Washington Post reports.